Opti Capital Management, LP - Q1 2022 holdings

$1.24 Billion is the total value of Opti Capital Management, LP's 42 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 78.4% .

 Value Shares↓ Weighting
 DICKS SPORTING GOODS INCnote 3.250% 4/1$92,431,000
-12.0%
29,655,0000.0%7.44%
-6.6%
BuyCONMED CORPnote 2.625% 2/0$86,599,000
+8.0%
50,065,000
+4.2%
6.97%
+14.7%
BuyPEGASYSTEMS INCnote 0.750% 3/0$64,238,000
+75.6%
67,730,000
+97.9%
5.17%
+86.3%
BuySAILPOINT TECHNOLOGIES HLDGSnote 0.125% 9/1$59,528,000
+34.5%
32,030,000
+29.3%
4.79%
+42.8%
NewDOCUSIGN INCnote 1/1$59,444,00063,178,000
+100.0%
4.78%
SellWORKIVA INCnote 1.125% 8/1$58,863,000
-14.9%
36,338,000
-6.9%
4.74%
-9.7%
BuyNEW RELIC INCnote 0.500% 5/0$52,879,000
+46.9%
52,250,000
+74.2%
4.26%
+55.9%
BuySUPERNUS PHARMACEUTICALSnote 0.625% 4/0$46,433,000
+2.8%
46,902,000
+3.3%
3.74%
+9.2%
Buy8X8 INC NEWnote 0.500% 2/0$44,806,000
+9.9%
47,575,000
+17.3%
3.61%
+16.7%
BuyVEECO INSTRS INC DELnote 3.750% 6/0$44,348,000
+9.5%
21,000,000
+13.5%
3.57%
+16.2%
BuyINSIGHT ENTERPRISES INCnote 0.750% 2/1$41,693,000
+11.2%
25,836,000
+10.7%
3.36%
+18.0%
NewON SEMICONDUCTOR CORPnote 1.625%10/1$41,603,00013,700,000
+100.0%
3.35%
BuyALTERYX INCnote 0.500% 8/0$40,422,000
+93.6%
43,481,000
+96.9%
3.25%
+105.6%
NewALARM COM HLDGS INCnote 1/1$39,269,00045,996,000
+100.0%
3.16%
SellIONIS PHARMACEUTICALS INCnote 0.125%12/1$38,559,000
+0.5%
42,382,000
-0.1%
3.10%
+6.6%
NewFASTLY INCnote 3/1$37,774,00050,000,000
+100.0%
3.04%
BuyMANDIANT INCnote 1.625% 6/0$36,309,000
+15.7%
36,309,000
+16.0%
2.92%
+22.8%
 ENVESTNET INCnote 1.750% 6/0$36,198,000
-4.5%
30,000,0000.0%2.91%
+1.4%
NewBLACKLINE INCnote 3/1$35,940,00042,333,000
+100.0%
2.89%
 KBR INCnote 2.500%11/0$34,838,000
+14.0%
16,000,0000.0%2.80%
+20.9%
NewEVERBRIDGE INCnote 0.125%12/1$33,256,00036,500,000
+100.0%
2.68%
NewCOUPA SOFTWARE INCnote 0.125% 6/1$28,855,00029,500,000
+100.0%
2.32%
 ZENDESK INCnote 0.625% 6/1$25,346,000
+5.8%
20,000,0000.0%2.04%
+12.3%
SellAVAYA HLDGS CORPnote 2.250% 6/1$25,300,000
-22.5%
25,792,000
-16.0%
2.04%
-17.8%
SellNUVASIVE INCnote 1.000% 6/0$17,937,000
-10.9%
17,910,000
-10.0%
1.44%
-5.4%
SellNOVA LTDnote 10/1$15,514,000
-67.8%
10,000,000
-58.8%
1.25%
-65.9%
NewWIX COM LTDnote 8/1$13,941,00016,012,000
+100.0%
1.12%
NewNEOGENOMICS INCnote 1.250% 5/0$13,592,00015,750,000
+100.0%
1.09%
 MODEL N INCnote 2.625% 6/0$13,321,000
-5.2%
12,000,0000.0%1.07%
+0.6%
 HESKA CORPnote 3.750% 9/1$11,898,000
-20.5%
6,616,0000.0%0.96%
-15.6%
SellKARYOPHARM THERAPEUTICS INCnote 3.000%10/1$9,548,000
-21.9%
11,460,000
-23.4%
0.77%
-17.1%
 PTC THERAPEUTICS INCnote 3.000% 8/1$8,206,000
-3.5%
8,000,0000.0%0.66%
+2.5%
NewNUTANIX INCnote 1/1$6,961,0006,992,000
+100.0%
0.56%
 OMEROS CORPnote 6.250%11/1$5,650,000
+0.9%
6,100,0000.0%0.46%
+7.1%
SellVIAVI SOLUTIONS INCnote 1.000% 3/0$4,040,000
-38.0%
3,096,000
-32.6%
0.32%
-34.2%
NewEVERBRIDGE INCnote 3/1$3,485,0004,000,000
+100.0%
0.28%
NewTHE REALREAL INCnote 3.000% 6/1$3,004,0003,500,000
+100.0%
0.24%
NewCOUPA SOFTWARE INCnote 0.375% 6/1$2,941,0003,500,000
+100.0%
0.24%
NewWESTERN DIGITAL CORP.note 1.500% 2/0$2,903,0003,000,000
+100.0%
0.23%
NewTWITTER INCnote 3/1$2,121,0002,500,000
+100.0%
0.17%
NewQ2 HLDGS INCnote 0.125%11/1$1,300,0001,500,000
+100.0%
0.10%
NewNEOGENOMICS INCnote 0.250% 1/1$1,003,0001,500,000
+100.0%
0.08%
ExitBIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0$0-8,095,000
-100.0%
-0.65%
ExitLENDINGTREE INCnote 0.500% 7/1$0-11,500,000
-100.0%
-0.73%
ExitMANDIANT INCnote 0.875% 6/0$0-10,216,000
-100.0%
-0.81%
ExitCOHERUS BIOSCIENCES INCnote 1.500% 4/1$0-17,650,000
-100.0%
-1.49%
ExitFORTIVE CORPnote 0.875% 2/1$0-21,927,000
-100.0%
-1.66%
ExitREPLIGEN CORPnote 0.375% 7/1$0-10,534,000
-100.0%
-1.88%
ExitNATIONAL VISION HLDGS INCnote 2.500% 5/1$0-16,591,000
-100.0%
-2.12%
ExitRAMBUS INC DELnote 1.375% 2/0$0-18,000,000
-100.0%
-2.15%
ExitVONAGE HLDGS CORPnote 1.750% 6/0$0-21,880,000
-100.0%
-2.23%
ExitETSY INCnote 0.125%10/0$0-27,500,000
-100.0%
-5.33%
ExitZSCALER INCnote 0.125% 7/0$0-41,140,000
-100.0%
-6.84%
ExitNATERA INCnote 2.250% 5/0$0-37,362,000
-100.0%
-7.29%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SUPERNUS PHARMACEUTICALS INC14Q1 20236.9%
NEW RELIC INC14Q1 20237.6%
8X8 INC NEW13Q3 20237.4%
MANDIANT INC12Q1 20229.9%
NUTANIX INC12Q4 20227.3%
OPKO HEALTH INC12Q3 20232.1%
INSIGHT ENTERPRISES INC10Q3 20235.6%
ALTERYX INC10Q3 20234.6%
IONIS PHARMACEUTICALS INC10Q1 20233.6%
MODEL N INC10Q3 20231.7%

View Opti Capital Management, LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Opti Capital Management, LP's complete filings history.

Compare quarters

Export Opti Capital Management, LP's holdings